Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 289-995-2 | CAS number: 90063-37-9 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Lavandula angustifolia, Labiatae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2009
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Effects of ultraviolet radiation on the kinetics of in vitro percutaneous absorption of lavender oil.
- Author:
- Ben Salah M, Abderraba M, Tarhouni MR and Abdelmelek H.
- Year:
- 2 009
- Bibliographic source:
- Int J Pharm. 382(1-2):33-38.
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- An in vitro percutaneous absorption study was conducted to investigate the absorption of lavender essential oil on the rat skin.
- GLP compliance:
- not specified
Test material
- Test material form:
- liquid
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Description: Pale-yellow liquid with a slightly camphoraceous odor - Radiolabelling:
- no
Administration / exposure
- Details on in vitro test system (if applicable):
- SKIN PREPARATION
- Source of skin: Wistar rat
- Type of skin: Dorsal skin of Wistar rat
- Preparative technique: Dorsal skin of Wistar rat (180–200 g) was shaved by an electric clipper a night before of experiment and then the excised skin was immediately mounted on the receptor compartment with the SC-side facing upwards into the donor compartment and the dermal side facing downwards into the receptor compartment.
- The receptor compartment was filled with 10mL of normal saline and stirred constantly using a mini magnetic stirrer. The temperature of the jacketed diffusion cell was regulated by water thermostat maintained at 37 °C.
- The diffusion area of the skin was 3.14cm^2.
PRINCIPLES OF ASSAY
In vitro skin permeation experiments were carried out using cell diffusion:
- Following the 30mn equilibration, the lavender oil (500 mg) was applied onto the skin. The donor compartment was occluded with Parafilm. The essential oil was left on the skin surface for 4, 8, 12 and 24 h. After that, it was removed, and the skin was rinsed shortly with ethanol. The stratum corneum (SC) layers were separated using fragments of an adhesive tape. Collected samples of SC as well as the remaining skin epidermis/dermis (ED) were extracted by shaking in 5mL of ethanol for 24 h at room temperature in tightly closed vials. The ethanol extracts were collected into chromatographic vials and stored at 4 °C before the chromatographic analysis. The acceptor medium was extracted by diethylic ether and collected for analysis. The absorption experiment was repeated in triplicates. In order to study the effect of ultraviolet radiation on percutaneous absorption, the same protocol was adopted except that the system was exposed to an ultraviolet lamp with a wavelength of 366 nm which characterize the UVAI band.
QUALITATIVE AND QUANTITATIVE ANALYSIS
- Lavender oil was analysed by gas chromatography using a Hewlett-Packard (HP) 6890 with the flame ionisation detector and split–splitless injector. The chromatographic conditions were as follows: the detector temperature was 300 °C; the initial oven temperature was isotherm at 35 °C for 10 min, increasing gradually 3 °C/min up to 205 °C and isotherm at 205 °C for 10 min. HP-Innowax capillary column having a polar stationary phase (polyethylene glycol) was used. Chemical components were identified by gas chromatography of the essential oils with authentic substances, and by calculating their retention indices.
- The percentage composition of the essential oil was computed from gas chromatography peak areas using a HP CHEMSTATION data system. The main components of the lavender oil in the extracts of SC, ED and acceptor medium were identified and their concentration was calculated from their GC peak areas using a HP CHEMSTATION.
Results and discussion
- Absorption in different matrices:
- - Skin preparation (in vitro test system):
The percutaneous absorption of lavender oil was studied by the determination of its main components quantities that was accumulated during the times of exposition, and the system was protected against evaporation. During different times, no terpenes were detected in the acceptor fluid. The amounts determined in the separated skin layers after 4, 8, 12 and 24 h. The data of cumulated terpenes amounts in SC (stratum corneum) and ED (epidermis and dermis) are presented in Table 7.1.2/1. The concentrations were not normalized in respect of the collected SC mass.
- The terpenes penetrated easily into the skin but with different amounts. However, the amount of all terpenes increased during the first 4 h, then decreased from 4 until 12 h and finally increased again at 24 h.
- It was observed that an increase of the compounds until 4 h of absorption; then, between 4 and 8 h, the compounds decreased linearly to reach a minimum at 12 h. Finally, from 12 until 24 h the compounds increased again.
- Percutaneous absorption of lavender oil under ultraviolet radiation:
The percutaneous absorption of lavender oil with ultraviolet radiation (366 nm) was studied by the determination of its main component quantities accumulated during the times of exposition, and the system was protected against evaporation. During different times, no terpenes were detected in the acceptor fluid. The amounts determined in the separated skin layers after 4 and 8 h are presented in Table 7.1.2/2. The concentrations were not normalized in respect of the collected SC mass.
- The ultraviolet radiation altered the cycle (charge-discharge) for terpenes (low lipophilicity) and increased the charge time. However, for terpenes (high lipophilicity), the ultraviolet radiation decreased the charge amplitude.
Percutaneous absorptionopen allclose all
- Key result
- Time point:
- 4 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 483 ± 141 and 309 ± 66 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Linalool
- Key result
- Time point:
- 8 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 327 ± 37 and 534 ± 198 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Linalool
- Key result
- Time point:
- 12 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 110 ± 35.50 and 507 ± 9 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Linalool
- Key result
- Time point:
- 24 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 884 ± 462 and 929 ± 94 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Linalool
- Key result
- Time point:
- 4 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 427 ± 127 and 140.50 ± 7 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Linalyl acetate
- Key result
- Time point:
- 8 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 235 ± 76 and 286 ± 112 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Linalyl acetate
- Key result
- Time point:
- 12 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 101 ± 35 and 236 ± 27 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Linalyl acetate
- Key result
- Time point:
- 24 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 670 ± 319 and 464 ± 19 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Linalyl acetate
- Key result
- Time point:
- 4 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 123 ± 44 and 27 ± 6 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Carvacrol
- Key result
- Time point:
- 8 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 101 ± 13 and 88.5 ± 44 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Carvacrol
- Key result
- Time point:
- 12 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 10 ± 5 and 42 ± 5 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Carvacrol
- Key result
- Time point:
- 24 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 65 ± 25 and 83 ± 17 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Carvacrol
- Key result
- Time point:
- 4 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 184 ± 55 and 163 ± 40 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Camphor
- Key result
- Time point:
- 8 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 125 ± 17 and 244 ± 96.50 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Camphor
- Key result
- Time point:
- 12 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 37 ± 11 and 251 ± 5 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Camphor
- Key result
- Time point:
- 24 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 976 ± 629 and 557 ± 107 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- Camphor
- Key result
- Time point:
- 4 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 155 ± 54 and 120 ± 35 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- 1,8-Cineol
- Key result
- Time point:
- 8 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 133 ± 21 and 183 ± 88.50 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- 1,8-Cineol
- Key result
- Time point:
- 12 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 114 ± 73 and 189 ± 24 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- 1,8-Cineol
- Key result
- Time point:
- 24 h
- Dose:
- 500 mg
- Parameter:
- amount
- Remarks on result:
- other: absorption: 340 ± 207 and 641 ± 197 µg/cm2 in stratum corneum and epidermis/dermis, respectively
- Remarks:
- 1,8-Cineol
Any other information on results incl. tables
Table 7.1.2/1: Absorption of Terpenes (µg/cm2) into rat skin layer
Test item |
Time of exposure skin layera |
|||
4 h |
8 h |
12 h |
24 h |
|
Linalool |
||||
SC |
483 ± 141 |
327 ± 37 |
110 ± 35.50** |
884 ± 462 |
ED |
309 ± 66 |
534 ± 198 |
507 ± 9 |
929 ± 94* |
Linalyl acetate |
||||
SC |
427 ± 127 |
235 ± 76 |
101 ± 35** |
670 ± 319 |
ED |
140.50 ± 7 |
286 ± 112 |
236 ± 27 |
464 ± 19** |
Carvacrol |
||||
SC |
123 ± 44 |
101 ± 13 |
10 ± 5 |
65 ± 25 |
ED |
27 ± 6 |
88.5 ± 44 |
42 ± 5 |
83 ± 17* |
Camphor |
||||
SC |
184 ± 55 |
125 ± 17 |
37 ± 11** |
976 ± 629 |
ED |
163 ± 40 |
244 ± 96.50 |
251 ± 5 |
557 ± 107* |
1,8-Cineol |
||||
SC |
155 ± 54 |
133 ± 21 |
114 ± 73 |
340 ± 207 |
ED |
120 ± 35 |
183 ± 88.50 |
189 ± 24 |
641 ± 197 |
Determinate from experiments repeated in triplicates independently (mean ± S.E.M., n = 3).
8 h vs 4 h, 12 h vs 4 h and 24 vs 4 h
aSC: stratum corneum; ED: epidermis and dermis
* p < 0.05
** p < 0.01
Table 7.1.2/2: Influence of UVAI radiation on Terpenes absorptions of (µg/cm2) into rat skin layer
Test item |
Time of exposure skin layera |
|
4 h |
8 h |
|
Linalool |
||
SC |
169 ± 37 |
218 ± 90* |
ED |
176.50 ± 12* |
317 ± 41 |
Linalyl acetate |
||
SC |
147 ± 40 |
76 ± 4** |
ED |
58 ± 7 |
75 ± 12 |
Carvacrol |
||
SC |
20 ± 5 |
11 ± 2 |
ED |
12 ± 2 |
14 ± 2 |
Camphor |
||
SC |
41 ± 13 |
129 ± 69 |
ED |
102 ± 6 |
166 ± 10* |
1,8-Cineol |
||
SC |
12 ± 1 |
127 ± 83 |
ED |
93 ± 4 |
166 ± 11.50* |
Mean ± S.E.M., n=3. 8 h vs 4 h.
aSC: stratum corneum; ED: epidermis and dermis
* p < 0.05
** p < 0.01Applicant's summary and conclusion
- Conclusions:
- The terpenes penetrated easily into the skin but with different amounts. The amount of all terpenes increased during the first 4 h, then decreased from 4 until 12 h and finally increased again at 24 h. The ultraviolet radiation altered the cycle (charge-discharge) for terpenes (low lipophilicity) and increased the charge time. However, for terpenes (high lipophilicity), the ultraviolet radiation decreased the charge amplitude.
- Executive summary:
An in vitro percutaneous absorption study was conducted to investigate the absorption of lavender essential oil on the rat skin. The pure oil was extracted from Lavandula angustifolia by steam distillation.
The essential oil (500 mg) was applied onto the rat skin and In vitro skin permeation experiments were carried out using cell diffusion. The diffusion area of the skin was 3.14 cm2. The essential oil was left on the skin surface for 4, 8, 12 and 24 h. The amount of the compounds was determined using gas chromatography. Similarly, the amount of these compounds was analyzed for the skin exposed to ultraviolet radiation (UVAI) after 4, 8, 12 and 24 h. The percutaneous absorption of lavender oil with or without ultraviolet radiation (366 nm) was studied by the determination of its main components quantities that was accumulated during the times of exposition, and the system was protected against evaporation.
The chemical composition of lavender oil showed that terpenes are major compounds. The chemical identification and the quantitative estimation of lavender oil showed that it contained five main components: linalool (25.18%), linalyl acetate (21.71%), 1,8-cineol (14.12%), camphor (11.15%) and carvacrol (2.34%).
During different times, no terpenes were detected in the acceptor fluid. The amounts determined in the separated skin layers after 4, 8, 12 and 24 h. The terpenes penetrated easily into the skin but with different amounts. However, the amount of all terpenes increased during the first 4 h, then decreased from 4 until 12 h and finally increased again at 24 h. It was observed that an increase of the compounds until 4 h of absorption; then, between 4 and 8 h, the compounds decreased linearly to reach a minimum at 12 h. Finally, from 12 until 24 h the compounds increased again.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.